The Patient Voice
Pharmaceutical products are made for patients, so it is essential that drug development incorporates the patient view
Sven Stegemann | | Longer Read
Launching new products is a source of growth and sustainability for any industry, but innovation is particularly important for pharma, which thrives on discovering new molecules for the treatment of acute and chronic diseases. Because of the pharma industry, effective therapies exist for the major chronic illnesses and, increasingly, for more complex and life-threatening diseases as well. Life expectancy has grown along with therapeutic advancements, but so too has the number of patients living with multimorbidity and polypharmacy. In addition, downsides have surfaced, including a rise in medication-related hospitalization, medication errors, and, unexpectedly, poor therapeutic outcomes.
Medication-related problems are a major cause of unplanned hospital or emergency department admissions, especially in older patients, as well as a leading cause of premature death in US hospitals (1). Hospital admissions could have been predicted and prevented in over 60 percent of cases (2), and it is estimated that over 80 percent of medication problems occur on the patient level (3). Today, there is increasing focus on seeing the patient as an active partner in medication management and therapeutic effectiveness – and ensuring that pharmaceutical products are usable in the real world to help patients take their medicines as intended.
Read the full article now
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine